- WB
Supplier Data
Western blot - Anti-AMBN antibody [EPR8317] (AB155950)
Blocking and diluting buffer and concentration : 5% NFDM /TBST. Exposure time : Lane 1 : 1 second. Lane 2 : 20 seconds. AMBN will migrate to higher MW size (PMID : 23782691), the MW is consistent with literature (PMID : 26070558).
Lane 1:
Western blot - Anti-AMBN antibody [EPR8317] (ab155950) at 1/1000 dilution
Lane 2:
Western blot - Anti-GST antibody [EPR4236] (<a href='/ko/products/primary-antibodies/gst-antibody-epr4236-ab111947'>ab111947</a>) at 1/1000 dilution
All lanes:
Recombinant AMBN protein
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 48 kDa
Observed band size: 100 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-AMBN antibody [EPR8317] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Nature 559:211-216 PubMed29973724
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com